<i>IRF5</i> siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis
These findings highlight the potential of siRNA nanoimmunotherapeutics for treating atherosclerosis and other diseases resulting from impaired efferocytosis in macrophages.
Authors
- Xiangrong Song (ORCID: https://orcid.org/0000-0002-2853-2696)
- Xi He (ORCID: https://orcid.org/0000-0001-9773-7495)
- Duotian Qin (ORCID: https://orcid.org/0000-0001-5023-2238)
- Zhong-Hui Duan (ORCID: https://orcid.org/0000-0001-6561-0991)
- Zhongshan He (ORCID: https://orcid.org/0000-0003-2108-7929)
- Yongjiang Li (ORCID: https://orcid.org/0000-0001-6882-7862)
- Zhuoming Zhou (ORCID: https://orcid.org/0000-0003-4996-0582)
- Yan Kang (ORCID: https://orcid.org/0000-0002-5715-3900)
- Chunling Jiang (ORCID: https://orcid.org/0000-0002-3625-8359)
- Haixing Shi (ORCID: https://orcid.org/0000-0001-6101-5562)
- Yaoyao Luo (ORCID: https://orcid.org/0009-0007-2708-4637)
- Ji Zhang (ORCID: https://orcid.org/0000-0002-2238-5824)
- Wei Chen (ORCID: https://orcid.org/0000-0002-2909-3023)
- Wanqin Zeng
- Bin Su (ORCID: https://orcid.org/0000-0001-5140-0440)
- Yu Guo (ORCID: https://orcid.org/0000-0001-6042-5332)
Institutions
- Brigham and Women's Hospital (US)
- Sichuan University (CN)
- Beijing YouAn Hospital (CN)
- Green Chemistry (PL)
Publication Details
- Journal
- Circulation
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1161/circulationaha.125.075352
- Citations
- 2
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.59